NCT00075270 arm group 0a6e71b1034abcd1f2d32e915b9fecee [clinicaltrials_resource:NCT00075270/arm-group/0a6e71b1034abcd1f2d32e915b9fecee]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00075270 arm group 0a6e71b1034abcd1f2d32e915b9fecee [clinicaltrials_resource:NCT00075270/arm-group/0a6e71b1034abcd1f2d32e915b9fecee]
Bio2RDF identifier
NCT00075270/arm-group/0a6e71b1034abcd1f2d32e915b9fecee
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 6e71b1034abcd1f2d32e915b9fecee
description [clinicaltrials_vocabulary:description]
Lapatinib 1500 mg, once daily ...... usly over 3 hours ever 3 weeks
identifier
clinicaltrials_resource:NCT00075270/arm-group/0a6e71b1034abcd1f2d32e915b9fecee
title
NCT00075270 arm group 0a6e71b1034abcd1f2d32e915b9fecee
@en
type
label
NCT00075270 arm group 0a6e71b1 ...... e71b1034abcd1f2d32e915b9fecee]
@en